SNORD94 and breast carcinoma: The U94 protein exhibits antiproliferative activity; additionally, its capability to inhibit cell motility, invasion, anchorage-independent growth, and to trigger partial MET was explored both in vitro and in vivo using the cervical cancer cells HeLa and the triple-negative human breast cancer cells (TNBC) MDA-MB-231 [9].